QA: Uniqure N V in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001590560_2017_Uniqure_N_V.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}

Graph

Absolute values for 0001590560, Uniqure N V

  xvar xval
0 AssetsCurrent 143,946,000
1 IntangibleAssetsNetIncludingGoodwill 8,789,000
2 PropertyPlantAndEquipmentNet 35,702,000
3 remainder_Assets 1,828,000
4 LiabilitiesCurrent 22,721,000
5 LiabilitiesNoncurrent 103,913,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 25,999,000
9 ResearchAndDevelopmentExpense 72,510,000
10 remainder_Expenses 3,317,000
11 remainder_Revenues 26,563,000
12 remainder_NetIncome 1,889,000
13 remainder_ComprehensiveNetIncome 271,000
  yvar yval
0 Assets 190,265,000
1 Liabilities 126,634,000
2 Expenses 101,826,000
3 Revenues 26,563,000
4 StockholdersEquity 63,631,000
5 NetIncome -73,374,000
6 ComprehensiveNetIncome -73,238,500
7 BaseVar 223,724,000
8 EconomicCapitalRatiobeforeLimitedLiability 0.413
9 EconomicCapitalRatio 1.80

Edgar->Model Mapping

Feature Distribution